Glenmark prints $170m CB with rare structure

Indian pharmaceutical company issued the convertible bond with a structure that allows the issuer to set the conversion price at a future date.

Indian drug research and manufacturing firm Glenmark Pharmaceuticals raised $170 million on Tuesday from a US dollar-denominated convertible bond with an unusual structure that has not been seen in Asia for over a decade.

Glenmark’s convertible bond was launched with a six-year tenor and an investor put exercisable after five years and a month. The deal was marketed at a base size of $150 million with a $50 million upsize option, which was partially exercised immediately before the close of the transaction.

The final offer size was settled at $170 million, although the company can still exercise the remaining $30 million of the upsize option within 60...

¬ Haymarket Media Limited. All rights reserved.

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222